Patrícia dos Santos Marcon

Patrícia dos Santos Marcon

Auto-generated profile, based on publicly available information

Patrícia dos Santos Marcon

Universidade Federal de Ciências da Saúde de Porto Alegre, Brasil; Hospital Mãe de Deu, Brasil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Medicine
Verified
Journal Article
Open access
LSLuciana dos Santos Schraiber
Luciana dos Santos Schraiber
AMAngelo Alves de Mattos
Angelo Alves de Mattos
MZMaria Lucia Zanotelli
Maria Lucia Zanotelli
GCGuido Pio Cracco Cantisani
Guido Pio Cracco Cantisani
ABAjácio Bandeira de Mello Brandão
Ajácio Bandeira de Mello Brandão
PMPatrícia dos Santos Marcon
Patrícia dos Santos Marcon
Hepatocellular carcinoma (HCC) is one of the leading causes of liver transplantation. In an attempt to predict their recurrence after liver transplantation, evaluation of tumor number and size, degree of histologic differentiation, and the presence of vascular invasion already have their importance established. In this context, the role of biologic markers such as alpha-fetoprotein (AFP) is still not clear. This retrospective cross-sectional study analyzed the AFP relationship with recurrence of HCC after orthotopic liver transplantation.The current study retrospectively analyzed data from 206 patients with a histopathologic confirmed HCC between 1997 and 2010.The overall survival rates at 1, 3, 5, and 14 years were 78.6%, 65.4%, 60.5%, and 38.7%, respectively. The frequency of recurrence was 15.5%, and recurrence was significantly associated with a lower survival rate (P < 0.001). No association was observed between survival and AFP level (P = 0.153). A correlation, however, was found between tumor recurrence and AFP level (P = 0.002). Univariate analysis of risk factors for recurrence revealed that an AFP level greater than 200 ng/mL, the number of tumors, the degree of cellular differentiation, and the presence of vascular invasion or satellite nodules were associated with relapse. By multivariate analysis, only an AFP level greater than 200 ng/mL remained as a risk factor.Although an elevated AFP level did not correlate with survival in HCC patients undergoing orthotopic liver transplantation, a high AFP level was associated with a 3.32-folds increase in the probability of HCC recurrence.

7 February 2018 in World Journal of Gastroenterology
Verified
Journal Article
Open access
PMPatrícia dos Santos Marcon
Patrícia dos Santos Marcon
CTCristiane Valle Tovo
Cristiane Valle Tovo
DKDimas Alexandre Kliemann
Dimas Alexandre Kliemann
PFPatrícia Fisch
Patrícia Fisch
AMAngelo Alves de Mattos
Angelo Alves de Mattos
Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study

1 March 2021 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
GCGabriela Perdomo Coral
Gabriela Perdomo Coral
FAFernanda Fortes De Araujo
Fernanda Fortes De Araujo
RMRosalva Meurer
Rosalva Meurer
PMPatrícia dos Santos Marcon
Patrícia dos Santos Marcon
PFPaulo Roberto Ott Fontes
Paulo Roberto Ott Fontes
AMAngelo Alves de Mattos
Angelo Alves de Mattos
BACKGROUND: Hepatocellular carcinoma (HCC) is the most frequent primary cancer of the liver and cirrhosis is considered a pre-malignant disease. In this context, the evolutionary sequence from low grade dysplastic nodule and high grade dysplastic nodule (HGDN) to early HCC and advanced HCC has been studied. The differential diagnosis between HGDN and early HCC is still a challenge, especially in needle biopsies OBJECTIVE: To evaluate an immunohistochemistry panel to differentiate dysplastic nodules and HCC. METHODS: Patients with cirrhosis who underwent surgical resection or liver transplantation were included. The sensitivity, specificity and accuracy for the diagnosis of neoplasia were analyzed by evaluating five markers: heat shock protein 70, glypican 3, glutamine synthetase, clathrin heavy chain and beta-catenin. P≤0.05 was considered statistically significant. RESULTS: One hundred and fifty-six nodules were included; of these, 57 were HCC, 14 HGDN, 18 low grade dysplastic nodules and 67 regenerative macronodules. Sensitivity of HCC diagnosis was 64.9% for glypican 3 and 77.2% for glutamine syntetase, while specificity was 96.0% and 96.0% respectively. When the panel of four markers was considered (excluding beta catenin), the specificity ranged from 87.9% for one positive marker to 100% for at least three markers. The best accuracy for HCC diagnosis was obtained with at least two positive markers, which was associated with a sensitivity of 82.5% and specificity of 99%. CONCLUSION: Differential diagnosis of dysplastic nodules and HCC by morphological criteria can be challenging. Immunomarkers are useful and should be used for the differential diagnosis between HCC and HGDN.

1 September 2019 in Annals of Hepatology
Verified
Journal Article
Open access
ARArlete F. Rech-Medeiros
Arlete F. Rech-Medeiros
PMPatrícia dos S. Marcon
Patrícia dos S. Marcon
CTCristiane Do V. Tovo
Cristiane Do V. Tovo
AMAngelo A. de Mattos
Angelo A. de Mattos
Viral hepatitis is a serious public health problem. The risk of progression to chronic hepatitis in hepatitis B virus (HBV) infection occurs in 5-10% of adults and is a leading cause of cirrhosis and hepatocellular carcinoma worldwide. Individuals infected with human immunodeficiency virus (HIV) may have coinfection with HBV. The existence of unvaccinated groups represents a significant risk not only individually but also at the community level. The aim of this study was to evaluate HBV vaccine response in adults with HIV infection. A retrospective, descriptive study of the cross-sectional type was carried out in an outpatient HIV referral center in southern Brazil. All medical records of adult HIV patients seen during January 2006 to December 2015 were selected. In statistical analysis, a significance level of 5% was used. Of the 201 patients evaluated with a complete vaccination scheme, 55.72% were males, with a mean age of 43.86±12.68 years. Vaccine response occurred in 80.10% (161/201) of the patients, and it did not correlate with age, CD4+ cell count or viral load. HBV vaccine response in a HIV population was satisfactory, highlighting the importance of vaccination for prevention, cost reduction and better prognosis in preventing HBV/HIV coinfection.

1 December 2015 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
AMAngelo Alves de Mattos
Angelo Alves de Mattos
PMPatrícia dos Santos Marcon
Patrícia dos Santos Marcon
FAFernanda Schild Branco de Araújo
Fernanda Schild Branco de Araújo
GCGabriela Perdomo Coral
Gabriela Perdomo Coral
CTCristiane Tovo
Cristiane Tovo
Chronic infection by hepatitis C virus (HCV) is one of the main risk factors for the development of liver cirrhosis and hepatocellular carcinoma. However, the emergence of hepatocellular carcinoma (HCC) in non-cirrhotic HCV patients, especially after sustained virological response (SVR) is an unusual event. Recently, it has been suggested that HCV genotype 3 may have a particular oncogenic mechanism, but the factors involved in these cases as well as the profile of these patients are still not fully understood. Thus, we present the case of a non-cirrhotic fifty-year-old male with HCV infection, genotype 3a, who developed HCC two years after treatment with pegylated-interferon and ribavirin, with SVR, in Brazil.

1 August 2020 in Hepatology
Verified
Journal Article
Closed access
PDF file
PMPatrícia dos Santos Marcon
Patrícia dos Santos Marcon
AMAngelo Zambam de Mattos
Angelo Zambam de Mattos
AMAngelo Alves de Mattos
Angelo Alves de Mattos